PRUDENTIAL FINANCIAL INC
For the period ended Dec 31, 2025. Filed Feb 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
21. Earnings Per Share
- EARNINGS PER SHARE
A reconciliation of the numerators and denominators of the basic and diluted per share computations of Common Stock based on the consolidated earnings of Prudential Financial for the years ended December 31, is as follows:
| 2025 · 2024 · 2023 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income · WeightedAverageShares · Per ShareAmount · Income · WeightedAverageShares · Per ShareAmount · Income · WeightedAverageShares · Per ShareAmount | |||||||||||||
| (in millions, except per share amounts) | |||||||||||||
| Basic earnings per share | |||||||||||||
| Net income (loss) | $3,732 | $2,846 | $2,508 | ||||||||||
| Less: Income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests | 156 | 119 | 20 | ||||||||||
| Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards | 41 | 32 | 29 | ||||||||||
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock | $3,535 | 351.8 | $10.05 | $2,695 | 357.5 | $7.54 | $2,459 | 363.5 | $6.76 | ||||
| Effect of dilutive securities and compensation programs | |||||||||||||
| Add: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Basic | $41 | $32 | $29 | ||||||||||
| Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Diluted | 41 | 32 | 29 | ||||||||||
| Stock options | 0.1 | 0.3 | 0.2 | ||||||||||
| Deferred and long-term compensation programs | 1.8 | 1.5 | 0.9 | ||||||||||
| Diluted earnings per share | |||||||||||||
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock | $3,535 | 353.7 | $9.99 | $2,695 | 359.3 | $7.50 | $2,459 | 364.6 | $6.74 | ||||
Unvested share-based payment awards that contain nonforfeitable rights to dividends are participating securities and included in the computation of earnings per share pursuant to the two-class method. Under this method, earnings attributable to Prudential Financial are allocated between Common Stock and the participating awards, as if the awards were a second class of stock. During periods of net income available to holders of Common Stock, the calculation of earnings per share excludes the income attributable to participating securities in the numerator and the dilutive impact of these securities from the denominator. In the event of a net loss available to holders of Common Stock, undistributed earnings are not allocated to participating securities and the denominator excludes the dilutive impact of these securities as they do not share in the losses of the Company. Undistributed earnings allocated to participating unvested share-based payment awards for the years ended December 31, 2025, 2024 and 2023, as applicable, were based on 3.8 million,4.0 million and 4.1 million of such awards, respectively, weighted for the period they were outstanding.
Stock options and shares related to deferred and long-term compensation programs that are considered antidilutive are excluded from the computation of diluted earnings per share. Stock options are considered antidilutive based on application of the treasury stock method or in the event of a net loss available to holders of Common Stock. Shares related to deferred and long-term compensation programs are considered antidilutive in the event of a net loss available to holders of Common Stock. For the years ended December 31, the number of stock options and shares related to deferred and long-term compensation programs that were considered antidilutive and were excluded from the computation of diluted earnings per share, weighted for the portion of the period they were outstanding, are as follows:
| 2025 · 2024 · 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · ExercisePrice PerShare · Shares · ExercisePrice PerShare · Shares · ExercisePrice PerShare | ||||||||
| (in millions, except per share amounts, based on weighted average) | ||||||||
| Antidilutive stock options based on application of the treasury stock method | 0.1 | $109.02 | 0.1 | $110.42 | 1.2 | $102.63 | ||
| Antidilutive stock options due to net loss available to holders of Common Stock | 0.0 | 0.0 | 0.0 | |||||
| Antidilutive shares based on application of the treasury stock method | 0.0 | 0.0 | 0.1 | |||||
| Antidilutive shares due to net loss available to holders of Common Stock | 0.0 | 0.0 | 0.0 | |||||
| Total antidilutive stock options and shares | 0.1 | 0.1 | 1.3 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.